Fabentech has received Marketing Authorisation in France for Ricimed, an antidote designed to treat ricin poisoning, marking ...
Oxford Drug Design has announced new in vivo results that further validate its emerging first‑in‑class oncology programme, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback